Sevasemten

N/A

Report date: 2024/05/20 11:53:11
NME

Base Information

Drug NameSevasemten
Drug Alias NameEDG-5506
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCreatine kinase inhibitorsTropomyosin inhibitors
TargetsCreatine kinaseTropomyosin
Therapy Area/IndicationsBecker muscular dystrophyLimb girdle muscular dystrophy 2IGlycogen Storage Disease Type V +[11] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesNetherlands +[12] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesEdgewise Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesEdgewise Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsBecker muscular dystrophyLimb girdle muscular dystrophy 2IGlycogen Storage Disease Type V +[9] 
Inactive IndicationsNervous System DiseasesMusculoskeletal Diseases

Other Information

ATC CodeN/A
Related LinksN/A